Filing Details
- Accession Number:
- 0001209191-10-041740
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-08-09 13:00:00
- Reporting Period:
- 2010-08-05
- Filing Date:
- 2010-08-09
- Accepted Time:
- 2010-08-09 17:00:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1006281 | Protalix Biotherapeutics Inc. | PLX | Biological Products, (No Disgnostic Substances) (2836) | 650643773 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1385118 | Yoseph Shaaltiel | C/O Protalix Biotherapeutics 2 Snunit Street, Science Park, Pob 455 Carmiel L3 20100 | Executive Vp, R&D | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-08-05 | 48,408 | $7.00 | 768,373 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-08-06 | 4,619 | $7.00 | 763,754 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Billionaire Hedge Funds
